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ABSTRACT: The scope of Viedma ripening and temperature
cycling with respect to chiral molecules has remained mostly
limited to molecules with a single stereogenic center, while
racemization proceeds through inversion at that particular
stereocenter. In this article we demonstrate for the ﬁrst time
that atropisomers, chiral rotamers that possess an axis of
chirality, can be successfully deracemized in the solid phase by
either applying temperature cycling or Viedma ripening.
■ INTRODUCTION
Single chirality is a key signature of living organisms and hence
of utmost importance to the development of new drugs in the
pharmaceutical industry. Obtaining molecules in an enantio-
pure way can however be troublesome, since straightforward
synthesis typically yields a racemic mixture of both
enantiomers. Viedma ripening is a process that converts a
saturated slurry of crystals of a racemic conglomerate into an
enantiopure end state by applying vigorous grinding. The ﬁrst
example of this process involved achiral sodium chlorate, which
crystallizes in a chiral fashion.1 Later studies have shown that
this deracemization process can also be applied to intrinsically
chiral molecules, such as amino acid derivatives,2 as well as to
the enantioselective synthesis of small molecules.3,4 Most of
these examples have focused on chiral molecules that exhibit an
sp3 hybridized carbon atom as a chiral center.5 Notable
exceptions include the work of the Hakansson group which
involves a chiral transition state metal complex,6 and one from
our own group where the chiral center is a sulfur atom.7 Other
important classes of chiral compounds also exist, but have
remained unexplored with regard to Viedma ripening.
One such class concerns atropisomers, nonplanar molecules
that display chirality through the hindered rotation around a
single bond, which in many cases can be overcome by raising
the temperature. Atropisomers can be very stable, however, as
is shown by the fact that quite a number of natural products
exist as atropisomers, featuring only one of the two possible
enantiomers.8 In addition, atropismerism is a common feature
in some drugs as well. An example is Telenzepine (1, Figure 1),
an antisecretory drug of which the (+)-atropisomer is the most
active form.9 In addition, axially chiral molecules such as
BINOL (2, 1,1-binaphthalene-2,2-diol) and BINAP (3, 2,2′-
bis(diphenylphosphanyl)-1,1′-binaphthalene) are often used as
ligands in transition metal based asymmetric synthesis.10 Here,
we report the deracemization of the atropisomer 4,6-dimethyl-
1-(naphthalen-1-yl)pyrimidine-2(1H)-thione (4, Figure 2)
using Viedma ripening or temperature cycling.
■ RESULTS AND DISCUSSION
Compound 4 was selected since it crystallizes as a racemic
conglomerate, which is a prerequisite for Viedma ripening. In
addition, this compound racemizes swiftly in apolar solvents at
elevated temperatures (t1/2 = 4 min in xylene at 50 °C),
whereas racemization at room temperature in polar solvents is
negligible.11 Racemization takes place relatively easily since it
proceeds via a reversible ring-opening and closing-mecha-
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Figure 1. Telenzepine (1) is an example of an atropisomer drug, while
BINOL (2) and BINAP (3) are chiral ligands often used in transition
metal complexes.
Figure 2. Atropisomer 4 crystallizes as a racemic conglomerate and
spontaneously racemizes at elevated temperatures in apolar solvents.
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nism,12 rather than via rotation around the chiral axis. Fujita
and co-workers already showed that total spontaneous
resolution can be achieved for this compound.11,13 By slowly
cooling a stirred, saturated solution of compound 4, seeded
with enantiopure crystals, they obtained an enantiomeric excess
(ee) of up to 90%. A drawback of these experiments is that the
deracemization was achieved only on small scale (50 mg). In
addition, such total spontaneous resolution experiments need
to be carried out in a carefully controlled manner, or
crystallization of the unwanted enantiomer will take place.
We investigate here whether alternative methods can be used to
deracemize a racemic mixture of compound 4. Viedma ripening
is a technique that can be applied on a much larger scale.14 In
addition, it starts from a racemic suspension of crystals, making
it a more robust method since unwanted crystallization of the
other enantiomer is no problem.15 As an alternative, we also
investigated the possibility of deracemization using temperature
cycling.16
Viedma Ripening Experiments. Viedma ripening experi-
ments on compound 4 resulted in an ee of around 90% (see
Experimental Section) with and without using a chiral bias.
Deracemization typically took 15−20 days at 60 °C. We found
that the outcome of the Viedma ripening experiments is
stochastic. Out of a total of six experiments (starting from
completely racemic conditions), three experiments yielded the
(Ra)- and three the (Sa)-enantiomer. This is in contrast to
previous examples of Viedma ripening, where often a bias was
found for one chiral end state, caused by the presence of chiral
impurities.17 Apparently this system is very pure or insensitive
toward a bias from impurities. When applying a small initial bias
(by adding less than 1% enantiopure material), deracemization
could be achieved in 15 days (Figure 3). During the ﬁltration,
the samples rapidly cooled down, resulting in additional
crystallization of both enantiomers. This is most likely the
reason the measured ee was 90%, while the actual value at the
end of the deracemization should be (close to) 100%.
Sonication Experiments. In order to decrease the time
required for deracemization, we evaluated diﬀerent exper-
imental conﬁgurations. Sonication of such a crystal suspension
can also result in deracemization18,19 and Noorduin et al. have
shown that this can greatly enhance the deracemization
speed.18 By replacing the magnetic stirrer with a sonication
bath, and starting from a small initial bias, deracemization could
indeed be achieved (Figure 3). Since no experiments without
an initial bias were performed, nothing can be said about the
stochasticity of this process. The drastic decrease in
deracemization time as described by Noorduin et al. was
however not observed. Since racemization, solubility, and
sonication energy20 are not limiting factors here, this could
possibly be due to a diﬀerent hardness of the crystals, although
no deﬁnite explanation can be given based on the current
experiments.
Temperature Cycling Experiments. Recently, the groups
of Flood and Coquerel described temperature cycling of a
suspension of conglomerate forming crystals as an alternative
method of deracemization.16,21 In this process, the suspension
is subjected to periodic heating−cooling cycles, resulting in
solid phase deracemization.22 By cycling the temperature
between 65 and 55 °C (again with an initial bias),
deracemization of 4 could also be achieved (Figure 3). The
time required for deracemization under these conditions is not
greatly diﬀerent from that of the Viedma ripening experiments.
Temperature cycling and Viedma ripening are however diﬃcult
to compare because of the diﬀerent conditions (temperature,
glass beads). In addition, the technique and temperature proﬁle
of the cycles have not been optimized for this speciﬁc system.23
■ CONCLUSION
In conclusion, we have successfully demonstrated the ﬁrst
example of the deracemization of an atropisomer using both
Viedma ripening and temperature cycling at gram scale. Both
methods enabled deracemization in 15−20 days at elevated
temperatures.
■ EXPERIMENTAL SECTION
Synthesis of 4,6-Dimethyl-1-(naphthalen-1-yl)pyrimidine-
2(1H)-thione (4). Ammonium thiocyanate (2.0 g, 26 mmol) was
added to 100 mL acetone (100 mL), followed by the dropwise
addition of benzoyl chloride (3.0 mL, 26 mmol). The resulting
suspension was reﬂuxed for 20 min and then allowed to cool to room
temperature. Next, 1-naphthaleneamine (2.5 g, 17.5 mmol) was added
and the mixture was reﬂuxed for 1 h. The solution was poured into
water (300 mL) and the resulting residue was ﬁltered oﬀ. The
precipitate was washed with water and added to 5% aqueous NaOH
(100 mL). The suspension was heated to 80 °C for 30 min and then
cooled to room temperature. 1 M aqueous HCl was added after which
the pH was adjusted to 9 by adding aqueous saturated Na2CO3. The
residue was ﬁltered oﬀ, washed with water, and dried in air to yield 1-
(naphthalen-1-yl)thiourea as a white powder in quantitative yield.
This product was added to ethanol (50 mL), followed by the
addition of 2,4-pentadione (2.5 mL, 24 mmol). Next, 5 M aqueous
HCl (20 mL) was added and the mixture was reﬂuxed for 3 h. The
mixture was added to ice-water containing NaOH (2.5 g). The
product was extracted using DCM and dried with MgSO4. The solvent
was removed after which a thick red oil was formed. Upon addition of
small quantities of acetone, product 4 precipitated as a yellow/orange
powder in 52% yield.
1H NMR (400 MHz, CDCl3): δ 7.97−7.90 (m, 2H), 7.60−7.55 (m,
1H), 7.54−7.44 (m, 2H), 7.41−7.38 (m, 1H), 7.38−7.35 (m, 1H),
6.59 (s, 1H), 2.48 (s, 3H), 1.89 (s, 3H). 13C NMR (100 MHz,
CDCl3): δ 184.9, 169.9, 158.3, 137.6, 134.6, 129.6, 128.8, 128.0, 127.8,
126.9, 125.8, 125.1, 121.2, 110.8, 25.0, 21.5.
Viedma Ripening Experiments. Compound 4 (800 mg), glass
beads (5 g, Ø ca. 2 mm VWR international), an oval PTFE-coated
magnetic stirring bar (L 20 mm, Ø 10 mm), and toluene (10 mL)
were added to a round-bottom ﬂask to which a condenser was
Figure 3. Deracemization curves of compound 4 using temperature
cycling, Viedma ripening, and sonication. In these experiments, a small
initial ee was created by adding less than 1% enantiopure material.
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attached. The vial was heated to 60 °C and stirred at 600 rpm. Samples
were taken regularly.
Sonication Experiments. Compound 4 (800 mg), glass beads (5
g, Ø ca. 2 mm VWR international), and toluene (10 mL) were added
to a round-bottom ﬂask. The ﬂask was sealed and placed inside a
sonication bath (35 kHz, 320W) at 60 °C. Samples were taken
regularly.
Temperature Cycling Experiments. Compound 4 (800 mg), an
oval PTFE-coated magnetic stirring bar (L 20 mm, Ø 10 mm), and
toluene (10 mL) were added to a round-bottom ﬂask to which a
condenser was attached. The temperature was cycled between 55 and
65 °C on a regular basis (5 min at 55 °C, 2 °C/min to 65 °C, 5 min at
65 °C, 1 °C/min to 55 °C), while the suspension was gently stirred.
Samples were taken after 5 min at 65 °C.
Sampling. For sampling, 100 μL of the suspension was taken using
a syringe. The crystals were ﬁltered oﬀ on a P4 glass ﬁlter and air-
dried.
Sample Analysis. Analysis of the samples taken during the
experiment was performed using chiral HPLC, which gave good
separation, but not the absolute conﬁguration of the two peaks in the
chromatogram. To determine the absolute conﬁguration, X-ray
diﬀraction was used to elucidate the structure of a single crystal.
Designation of the HPLC peaks was done by sampling this single
crystal, giving only a single peak.
The ee of the samples was determined using chiral HPLC (ADH
column, 20% IPA in heptane, ﬂow 1 mL min−1, retention times: (Sa)-4
11.7 min, (Ra)-4 25.0 min).
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